Biomarkers for predicting immunotherapy response and resistance in glioblastoma - Top-Institutions - MDSpire

Biomarkers for predicting immunotherapy response and resistance in glioblastoma

  • By

  • Samuel Kim

  • Matthew Abikenari

  • Brandon Bergsneider

  • Lily H. Kim

  • Michael Lim

  • May 5, 2026

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Center
    Dana-Farber Cancer Center

    Boston, MA

    Key Differentiators

    • Oncology

  • #3

    Northwestern University
    Northwestern University

    Chicago, IL

    Key Differentiators

    • Oncology

Original Source(s)

Biomarkers for predicting immunotherapy response and resistance in glioblastoma

  • by Samuel Kim, Matthew Abikenari, Brandon Bergsneider, Lily H. Kim, Michael Lim

  • May 5, 2026

Related Content

Efficacy and Safety of Neoadjuvant Therapies for High-Risk and Locally Advanced Prostate Cancer in Older Adults: A Systematic Review and Network Meta-Analysis

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma

Case Report: Cardiac metastasis of sarcomatoid urothelial carcinoma